Karyopharm outlines $130M-$150M 2026 revenue outlook as it prepares mid-2026 XPORT-EC-042 readout
Karyopharm Therapeutics Inc. · PHARMACEUTICAL PREPARATIONS · Now $9.82
-16% in 3d after detection
Post-detection moves
1h
—
1d
-14%
3d
-16%
7d
+0.8%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS